Billionaire David Koch to retire from Koch Industries, political network
 
 
Citing health issues, billionaire David Koch, 78, will step down from his roles at Koch Industries and the political activism network he runs with his brother, Charles Koch.
"Unfortunately, these issues have not been resolved, and his health has continued to deteriorate," Charles wrote in a letter sent to Koch Industries employees Tuesday. "As a result, he is unable to be involved in business and other organizational activities." Charles praised David's "guidance and loyalty, especially in our most troubling times."
This news comes just one day after the Kochs' political network announced a major new campaign against President Trump's tariffs. Long reviled on the left for their economic policy, in recent years the Kochs have made allies on both sides of the aisle on issues like immigration and criminal justice reform.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
 
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Koch Industries is the second-largest private company in the United States. David Koch will be named director emeritus.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Bonnie Kristian was a deputy editor and acting editor-in-chief of TheWeek.com. She is a columnist at Christianity Today and author of Untrustworthy: The Knowledge Crisis Breaking Our Brains, Polluting Our Politics, and Corrupting Christian Community (forthcoming 2022) and A Flexible Faith: Rethinking What It Means to Follow Jesus Today (2018). Her writing has also appeared at Time Magazine, CNN, USA Today, Newsweek, the Los Angeles Times, and The American Conservative, among other outlets.
- 
 Testosterone therapy in women highlights the lack of women’s health research Testosterone therapy in women highlights the lack of women’s health researchThe explainer There is no FDA-approved testosterone product for women 
- 
 Magazine solutions - November 7, 2025 Magazine solutions - November 7, 2025Puzzles and Quizzes Issue - November 7, 2025 
- 
 Magazine printables - November 7, 2025 Magazine printables - November 7, 2025Puzzles and Quizzes Issue - November 7, 2025 
- 
 Warner Bros. explores sale amid Paramount bids Warner Bros. explores sale amid Paramount bidsSpeed Read The media giant, home to HBO and DC Studios, has received interest from multiple buying parties 
- 
 Gold tops $4K per ounce, signaling financial unease Gold tops $4K per ounce, signaling financial uneaseSpeed Read Investors are worried about President Donald Trump’s trade war 
- 
 Electronic Arts to go private in record $55B deal Electronic Arts to go private in record $55B dealspeed read The video game giant is behind ‘The Sims’ and ‘Madden NFL’ 
- 
 New York court tosses Trump's $500M fraud fine New York court tosses Trump's $500M fraud fineSpeed Read A divided appeals court threw out a hefty penalty against President Trump for fraudulently inflating his wealth 
- 
 Trump said to seek government stake in Intel Trump said to seek government stake in IntelSpeed Read The president and Intel CEO Lip-Bu Tan reportedly discussed the proposal at a recent meeting 
- 
 US to take 15% cut of AI chip sales to China US to take 15% cut of AI chip sales to ChinaSpeed Read Nvidia and AMD will pay the Trump administration 15% of their revenue from selling artificial intelligence chips to China 
- 
 NFL gets ESPN stake in deal with Disney NFL gets ESPN stake in deal with DisneySpeed Read The deal gives the NFL a 10% stake in Disney's ESPN sports empire and gives ESPN ownership of NFL Network 
- 
 Samsung to make Tesla chips in $16.5B deal Samsung to make Tesla chips in $16.5B dealSpeed Read Tesla has signed a deal to get its next-generation chips from Samsung 
